Dogwood Wealth Management LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2056922
LENEXA, KS
Position in ALNY
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$9,030
+$4,729 QoQ
Shares Held
30
+130.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#77
of 96 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dogwood Wealth Management LLC holds $110,687 across 22 Biotechnology names. ALNY ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50 | $24,836 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32 | $19,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
30 | $9,030 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
39 | $7,303 | |
| 5 | RPRX |
Royalty Pharma plc
|
95 | $5,326 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
9 | $4,832 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
59 | $4,809 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
80 | $4,363 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,030 | 30 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,301 | 13 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,327 | 31 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,120 | 20 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,521 | 20 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $540 | 2 | Shares | Sole | 2025-04-30 | |
| 2024-09-30 | $0 | 0 | Shares | Sole | 2025-02-28 | |
| 2024-06-30 | $0 | 0 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $0 | 0 | Shares | Sole | 2025-02-28 | |
| 2023-12-31 | $0 | 0 | Shares | Sole | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||